查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586123

心臟再同步治療設備市場：按產品、最終用戶分類 - 全球預測 2025-2030 年

Cardiac Resynchronization Therapy Devices Market by Product (Cardiac Resynchronization Therapy Defibrillators, Cardiac Resynchronization Therapy Pacemakers), End-User (Ambulatory Surgery Centers, Hospitals & Cardiac Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心臟再同步治療設備市場價值為49.8億美元，預計2024年將達53.6億美元，複合年成長率為7.70%，到2030年將達到83.8億美元。

心臟再同步治療（CRT）設備透過電脈衝提高心臟的效率和收縮協調性，在心臟衰竭的治療中發揮至關重要的作用。心臟相關疾病（尤其是心臟衰竭）的日益普及推動了對 CRT 的需求，而世界人口老化、久坐生活方式的增加以及肥胖率的上升往往加劇了心臟衰竭。這些設備主要用於治療傳統治療方法不足以治療嚴重心臟衰竭的患者。無線 CRT 和多點起搏等技術進步正在將最終用途擴大到醫院、診所和心臟護理中心。

主要市場統計
基準年[2023] 49.8億美元
預測年份 [2024] 53.6億美元
預測年份 [2030] 83.8億美元
複合年成長率（%） 7.70%

根據市場洞察，一個關鍵的成長要素是人們對心血管疾病的認知不斷提高以及由此引起的對預防性醫療保健的關注。技術創新和有利的報銷政策也推動了 CRT 設備的採用。然而，高設備成本、潛在副作用和嚴格的監管核准流程等限制可能會對市場成長帶來挑戰。此外，缺乏熟練的專業人員來操作這些設備限制了它們的採用，特別是在發展中地區。潛在的機會在於透過策略聯盟擴大市場覆蓋範圍，並利用人工智慧和巨量資料分析的興起來改善設備功能和患者治療結果。

專注於降低設備成本、延長電池壽命和提高患者依從性的研究投資可以刺激創新。此外，開拓的微創植入技術可以擴大市場接受度。隨著以患者為中心的護理成為優先事項，用於遠端監控和個人化治療的智慧技術的整合仍然至關重要。由於技術創新和醫療保健支出的增加，市場競爭激烈且快速發展。解決可及性和病患教育的差距可以獲得顯著的紅利。透過專注於技術創新、策略夥伴關係以及企業發展到新興市場，在這一領域營運的公司將在克服市場挑戰的同時看到巨大的成長機會。

市場動態：快速發展的心臟再同步治療設備市場的關鍵市場洞察

心臟再同步治療設備市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 心血管疾病和目標疾病的發生率增加
    • 全球加護病房數量不斷增加
    • 已開發國家和新興國家醫療保健支出快速成長
  • 市場限制因素
    • CRT設備高成本
  • 市場機會
    • 心臟再同步治療設備中先進技術的整合
    • 新型和創新的 CRT 設備簡介
  • 市場挑戰
    • 缺乏操作心臟再同步治療裝置的熟練人員

波特五力：引領心臟再同步治療設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心臟再同步治療設備市場的外部影響

外部宏觀環境因素在塑造心臟再同步治療設備市場的性能動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心臟再同步治療設備市場的競爭格局

心臟再同步治療設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心臟再同步治療設備市場供應商的績效評估

FPNV定位矩陣是評估心臟再同步治療設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了心臟再同步治療設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對心臟再同步治療設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病和目標疾病的發生率增加
      • 全球加護病房數量不斷增加
      • 已開發國家和新興國家的醫療費用快速增加
    • 抑制因素
      • CRT設備高成本
    • 機會
      • 心臟再同步治療設備中先進技術的整合
      • 新型創新 CRT 設備簡介
    • 任務
      • 缺乏操作心臟再同步治療裝置的熟練人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心臟再同步治療設備市場：依產品

  • 心臟再同步治療心臟去顫器
  • 心臟再同步治療心律調節器

第7章心臟再同步治療設備市場：依最終使用者分類

  • 門診手術中心
  • 醫院和心臟中心

第8章美洲心臟再同步治療設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太心臟再同步治療設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲心臟再同步治療設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Biotronik AG
  • Boston Scientific Corporation
  • EBR Systems, Inc.
  • General Electric Company
  • Japan Lifeline Co., Ltd.
  • Koninklijke Philips NV
  • Livanova PLC
  • MEDICO SRL
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Microport Scientific Corporation
  • Osypka Medical GmbH
  • Siemens AG
  • St. Jude Medical, LLC
Product Code: MRR-433AB1DC2896

The Cardiac Resynchronization Therapy Devices Market was valued at USD 4.98 billion in 2023, expected to reach USD 5.36 billion in 2024, and is projected to grow at a CAGR of 7.70%, to USD 8.38 billion by 2030.

Cardiac Resynchronization Therapy (CRT) devices play a pivotal role in managing heart failure by improving the heart's efficiency and coordination of its contractions through electrical impulses. The necessity for CRT devices stems from the growing prevalence of heart-related disorders, especially heart failure, which is often exacerbated by an aging global population, increasing sedentary lifestyles, and rising obesity rates. These devices are primarily used to treat individuals suffering from severe heart dysfunction when conventional therapies prove insufficient. The end-use scope extends to hospitals, clinics, and specialized heart care centers, driven by technological advancements like wireless CRTs and multi-point pacing.

KEY MARKET STATISTICS
Base Year [2023] USD 4.98 billion
Estimated Year [2024] USD 5.36 billion
Forecast Year [2030] USD 8.38 billion
CAGR (%) 7.70%

Market insights reveal that significant growth factors are the rising awareness of cardiovascular diseases and the subsequent focus on preventive healthcare. Technological innovations and favorable reimbursement policies also boost the adoption of CRT devices. However, limitations like high device costs, potential side effects, and the stringent regulatory approval process can pose challenges to market growth. Additionally, a lack of skilled professionals to operate these devices limits their widespread adoption, especially in developing regions. Potential opportunities lie in expanding market reach through strategic collaborations and leveraging emerging artificial intelligence and big data analytics to refine device functionalities and patient outcomes.

Investment in research focusing on reducing device costs, enhancing battery life, and improving patient compliance can stimulate innovation. Developing minimally invasive implantation techniques can also widen market acceptance. With patient-centered care becoming a priority, integrating smart technologies for remote monitoring and personalized therapy remains crucial. The nature of the market is competitive and rapidly evolving, driven by technological breakthroughs and increasing healthcare expenditure. Addressing the gaps in accessibility and patient education could yield substantial dividends. For businesses operating in this domain, a focus on technological innovation, strategic partnerships, and expanding in emerging markets could unlock substantial growth opportunities while overcoming prevailing market challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Resynchronization Therapy Devices Market

The Cardiac Resynchronization Therapy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of cardiovascular and target diseases
    • Growing number of intensive care units globally
    • Surge in healthcare expenditure across developed and developing countries
  • Market Restraints
    • High cost of CRT devices
  • Market Opportunities
    • Integration of advanced technologies in cardiac resynchronization therapy devices
    • Introduction of new and innovative CRT devices
  • Market Challenges
    • Lack of skilled personnel to operate cardiac resynchronization therapy devices

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Resynchronization Therapy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Resynchronization Therapy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Resynchronization Therapy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Resynchronization Therapy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Resynchronization Therapy Devices Market

A detailed market share analysis in the Cardiac Resynchronization Therapy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Resynchronization Therapy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Resynchronization Therapy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Resynchronization Therapy Devices Market

A strategic analysis of the Cardiac Resynchronization Therapy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Resynchronization Therapy Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biotronik AG, Boston Scientific Corporation, EBR Systems, Inc., General Electric Company, Japan Lifeline Co., Ltd., Koninklijke Philips N.V., Livanova PLC, MEDICO S.R.L., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Osypka Medical GmbH, Siemens AG, and St. Jude Medical, LLC.

Market Segmentation & Coverage

This research report categorizes the Cardiac Resynchronization Therapy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Resynchronization Therapy Defibrillators and Cardiac Resynchronization Therapy Pacemakers.
  • Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals & Cardiac Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cardiovascular and target diseases
      • 5.1.1.2. Growing number of intensive care units globally
      • 5.1.1.3. Surge in healthcare expenditure across developed and developing countries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of CRT devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies in cardiac resynchronization therapy devices
      • 5.1.3.2. Introduction of new and innovative CRT devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled personnel to operate cardiac resynchronization therapy devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Resynchronization Therapy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Resynchronization Therapy Defibrillators
  • 6.3. Cardiac Resynchronization Therapy Pacemakers

7. Cardiac Resynchronization Therapy Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Hospitals & Cardiac Centers

8. Americas Cardiac Resynchronization Therapy Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiac Resynchronization Therapy Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Resynchronization Therapy Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Biotronik AG
  • 3. Boston Scientific Corporation
  • 4. EBR Systems, Inc.
  • 5. General Electric Company
  • 6. Japan Lifeline Co., Ltd.
  • 7. Koninklijke Philips N.V.
  • 8. Livanova PLC
  • 9. MEDICO S.R.L.
  • 10. Medtronic PLC
  • 11. Merit Medical Systems, Inc.
  • 12. Microport Scientific Corporation
  • 13. Osypka Medical GmbH
  • 14. Siemens AG
  • 15. St. Jude Medical, LLC

LIST OF FIGURES

  • FIGURE 1. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY HOSPITALS & CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023